SeaStar Medical Holding Price to Book Ratio 2021-2024 | ICU
Historical price to book ratio values for SeaStar Medical Holding (ICU) over the last 10 years. The current price to book ratio for SeaStar Medical Holding as of April 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| SeaStar Medical Holding Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-04-30 | 1.29 | 0.00 | |
| 2024-12-31 | 1.94 | $-0.37 | -5.31 |
| 2024-09-30 | 4.26 | $-0.49 | -8.75 |
| 2024-06-30 | 7.59 | $-2.14 | -3.54 |
| 2024-03-31 | 18.35 | $-1.48 | -12.38 |
| 2023-12-31 | 11.08 | $-6.88 | -1.61 |
| 2023-09-30 | 6.60 | $-14.62 | -0.45 |
| 2023-06-30 | 13.00 | $-15.79 | -0.82 |
| 2023-03-31 | 46.50 | $-20.46 | -2.27 |
| 2022-12-31 | 102.50 | $-40.87 | -2.51 |
| 2022-09-30 | 257.00 | $-82.67 | -3.11 |
| 2022-06-30 | 254.00 | $-65.03 | -3.91 |
| 2022-03-31 | 253.00 | $-66.72 | -3.79 |
| 2021-12-31 | 251.00 | $-9.73 | -25.81 |
| 2021-09-30 | 251.00 | $-99.19 | -2.53 |
| 2021-06-30 | 247.75 | $30.26 | 8.19 |
| 2021-03-31 | 245.25 | $42.15 | 5.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.012B | $0.000B |
| SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.368B | 26.70 |
| Elevance Health (ELV) | United States | $93.458B | 12.06 |
| CVS Health (CVS) | United States | $81.990B | 12.00 |
| Cencora (COR) | United States | $56.269B | 20.42 |
| Natera (NTRA) | United States | $20.939B | 0.00 |
| DiDi Global (DIDIY) | China | $20.365B | 29.93 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| ICON (ICLR) | Ireland | $12.058B | 10.95 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.881B | 0.00 |
| Solventum (SOLV) | United States | $11.461B | 10.69 |
| CochLear (CHEOY) | Australia | $11.380B | 0.00 |
| Revvity (RVTY) | United States | $11.373B | 19.20 |
| Doximity (DOCS) | United States | $10.781B | 56.07 |
| Viatris (VTRS) | United States | $9.955B | 3.15 |
| Medpace Holdings (MEDP) | United States | $8.805B | 23.39 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.152B | 0.00 |
| HealthEquity (HQY) | United States | $7.475B | 36.77 |
| Charles River Laboratories (CRL) | United States | $5.761B | 11.36 |
| Bausch + Lomb (BLCO) | Canada | $4.848B | 22.13 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Alignment Healthcare (ALHC) | United States | $3.446B | 0.00 |
| Organon (OGN) | United States | $3.421B | 3.45 |
| GeneDx Holdings (WGS) | United States | $3.283B | 389.90 |
| Sotera Health (SHC) | United States | $3.210B | 18.54 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.863B | 32.84 |
| Concentras Parent (CON) | United States | $2.815B | 14.64 |
| Progyny (PGNY) | United States | $1.967B | 43.32 |
| Premier (PINC) | United States | $1.862B | 11.92 |
| Ardent Health Partners (ARDT) | United States | $1.806B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.788B | 38.83 |
| Agilon Health (AGL) | United States | $1.569B | 0.00 |
| PACS (PACS) | United States | $1.486B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.285B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.078B | 9.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $1.008B | 17.10 |
| Establishment Labs Holdings (ESTA) | $0.873B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.770B | 6.09 |
| Embecta (EMBC) | United States | $0.730B | 5.00 |
| Nutex Health (NUTX) | United States | $0.579B | 11.35 |
| QDM (QDMI) | Hong Kong, SAR China | $0.554B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.530B | 14.04 |
| Sonida Senior Living (SNDA) | United States | $0.444B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 37.90 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.347B | 0.00 |
| DocGo (DCGO) | United States | $0.233B | 9.50 |
| Oncology Institute (TOI) | United States | $0.189B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Beauty Health (SKIN) | United States | $0.125B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.089B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 6.32 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |